scorecardresearch
Follow Us:
Tuesday, May 11, 2021

EU lifts export ban on Ranbaxy’s Toansa plant

The EMA said European regulatory authorities have finalised their assessment of reported non-compliance with Good Manufacturing Practice at the Toansa plant.

By: Press Trust of India | New Delhi |
June 6, 2014 1:37:48 am

European health regulator on Thursday lifted suspension imposed on export of drugs produced at Ranbaxy’s Toansa plant to the EU stating medicines produced at the site posed no risk to public health despite having a number of manufacturing deficiencies.

In a statement, the European Medicines Agency (EMA) said European regulatory authorities have finalised their assessment of reported non-compliance with Good Manufacturing Practice (GMP) at the Toansa plant.

“There were a number of GMP deficiencies at the concerned site, assessment of all available information has reassured European regulators that there has been no risk to public health from these deficiencies,” it said.

📣 The Indian Express is now on Telegram. Click here to join our channel (@indianexpress) and stay updated with the latest headlines

For all the latest Business News, download Indian Express App.

  • The Indian Express website has been rated GREEN for its credibility and trustworthiness by Newsguard, a global service that rates news sources for their journalistic standards.
Advertisement
Advertisement
Advertisement
Advertisement
X
x